Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of skin physiology (HP:0011122)help
Grandparent Node:
expand
Increased inflammatory response (HP:0012649)help
Parent Node:
expand
Inflammatory abnormality of the skin (HP:0011123)help
..Starting node
..expand
Eczema (HP:0000964)help
Term ID: 964
Name: Eczema
Synonym: Eczema
Definition: Eczema is a form of dermatitis. The term eczema is broadly applied to a range of persistent skin conditions and can be related to a number of underlying conditions. Manifestations of eczema can include dryness and recurring skin rashes with redness, skin edema, itching and dryness, crusting, flaking, blistering, cracking, oozing, or bleeding.
Comments:
Reference: HP:0000964
Genes and Diseases:
 
       Child Nodes:
........expandEczematoid dermatitis (HP:0000976) help
........expandSeborrheic dermatitis (HP:0001051) help
................... HP:0007569 Generalized seborrheic dermatitis
........expandPerioral eczema (HP:0011127) help

 Sister Nodes: 
..expandAcne (HP:0001061) help
..expandAtopic dermatitis (HP:0001047) help
..expandCrusting erythematous dermatitis (HP:0007473) help
..expandCutaneous abscess (HP:0031292) help
..expandDeep dermal perivascular inflammatory infiltrate (HP:0031191) help
..expandErysipelas (HP:0001055) help
..expandErythema nodosum (HP:0012219) help
..expandErythroderma (HP:0001019) help
..expandFolliculitis (HP:0025084) help
..expandNeutrophilic infiltration of the skin (HP:0031234) help
..expandPerifolliculitis (HP:0012322) help
..expandPsoriasiform dermatitis (HP:0003765) help
..expandPustule (HP:0200039) help
..expandRecurrent skin infections (HP:0001581) help
..expandSkin rash (HP:0000988) help
..expandSuperficial dermal perivascular inflammatory infiltrate (HP:0031190) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0000964HP:0000964Eczema0CASP8 CL E G H841607271Caspase-8 deficiency607271C1846545OMIM1121391509601763
HP:0000964HP:0000964Eczema0CD28 CL E G H9402584ORPHA1271653186760
HP:0000964HP:0000964Eczema0CD3G CL E G H917615607Immunodeficiency 17615607C3810107OMIM14851675186740
HP:0000964HP:0000964Eczema0COL1A1 CL E G H1277287ORPHA196711052197120150
HP:0000964HP:0000964Eczema0COL5A1 CL E G H1289287ORPHA115916302209120215
HP:0000964HP:0000964Eczema0COL5A2 CL E G H1290287ORPHA1397932210120190
HP:0000964HP:0000964Eczema0CSTA CL E G H1475263534ORPHA18232481184600
HP:0000964HP:0000964Eczema0CTLA4 CL E G H14932584ORPHA1721142505123890
HP:0000964HP:0000964Eczema0DHCR7 CL E G H1717270400Smith-Lemli-Opitz syndrome270400C0175694OMIM12183762860602858
HP:0000964HP:0000964Eczema0DNAJC21 CL E G H134218811Balo diseaseORPHA1116027030617048
HP:0000964HP:0000964Eczema0DNAJC21 CL E G H134218617052Bone marrow failure syndrome 3617052C4310744OMIM1116027030617048
HP:0000964HP:0000964Eczema0DOCK8 CL E G H81704243700Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive243700C1968689OMIM1169118119191611432
HP:0000964HP:0000964Eczema0EDA CL E G H1896305100Hypohidrotic X-linked ectodermal dysplasia305100C0162359OMIM13303473157300451
HP:0000964HP:0000964Eczema0EFL1 CL E G H79631811Balo diseaseORPHA135725789617538
HP:0000964HP:0000964Eczema0FECH CL E G H2235177000Erythropoietic protoporphyria177000C0162568OMIM11952173647612386
HP:0000964HP:0000964Eczema0FOXP3 CL E G H50943304790Insulin-dependent diabetes mellitus secretory diarrhea syndrome304790C0342288OMIM11082566106300292
HP:0000964HP:0000964Eczema0GINS1 CL E G H9837617827IMMUNODEFICIENCY 55617827CN737162OMIM143728980610608
HP:0000964HP:0000964Eczema0HDAC4 CL E G H97591001Branchial arch defectsORPHA11622314063605314
HP:0000964HP:0000964Eczema0HLA-DQB1 CL E G H3119703ORPHA115124944604305
HP:0000964HP:0000964Eczema0HLA-DRB1 CL E G H3123703ORPHA126194948142857
HP:0000964HP:0000964Eczema0IL2RA CL E G H3559606367Interleukin 2 receptor, alpha, deficiency of606367C1853392OMIM1191766008147730
HP:0000964HP:0000964Eczema0IL7R CL E G H3575608971Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive608971C1837028OMIM1592406024146661
HP:0000964HP:0000964Eczema0KANSL1 CL E G H284058610443Koolen-de Vries syndrome610443C1864871OMIM17284024565612452
HP:0000964HP:0000964Eczema0KRT1 CL E G H38482199ExencephalyORPHA1651336412139350
HP:0000964HP:0000964Eczema0KRT16 CL E G H38682199ExencephalyORPHA131596423148067
HP:0000964HP:0000964Eczema0KRT9 CL E G H38572199ExencephalyORPHA1311096447607606
HP:0000964HP:0000964Eczema0LIG4 CL E G H3981235ORPHA1403176601601837
HP:0000964HP:0000964Eczema0MBTPS2 CL E G H513602273Fara Chlupackova syndromeORPHA12620715455300294
HP:0000964HP:0000964Eczema0MSN CL E G H4478300988Immunodeficiency 50300988C4310812OMIM121347373309845
HP:0000964HP:0000964Eczema0MYSM1 CL E G H114803618116BONE MARROW FAILURE SYNDROME 4618116CN253834OMIM132629401612176
HP:0000964HP:0000964Eczema0NOD2 CL E G H64127186580Blau syndrome186580C1861303OMIM11214425331605956
HP:0000964HP:0000964Eczema0NSMCE3 CL E G H56160617241Lung disease, immunodeficiency, and chromosome breakage syndrome617241C4310653OMIM121377677608243
HP:0000964HP:0000964Eczema0NSUN2 CL E G H54888235ORPHA1726025994610916
HP:0000964HP:0000964Eczema0PAH CL E G H505379254ORPHA19809208582612349
HP:0000964HP:0000964Eczema0PAH CL E G H5053261600Phenylketonuria261600C0031485OMIM19809208582612349
HP:0000964HP:0000964Eczema0PCCA CL E G H5095606054Propionyl-CoA carboxylase deficiency606054C0268579OMIM11493878653232000
HP:0000964HP:0000964Eczema0PCCB CL E G H5096606054Propionyl-CoA carboxylase deficiency606054C0268579OMIM11313018654232050
HP:0000964HP:0000964Eczema0PGM3 CL E G H5238615816Immunodeficiency 23615816C4014371OMIM1161088907172100
HP:0000964HP:0000964Eczema0PTPRC CL E G H5788608971Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive608971C1837028OMIM182259666151460
HP:0000964HP:0000964Eczema0SBDS CL E G H51119811Balo diseaseORPHA1906019440607444
HP:0000964HP:0000964Eczema0SIK3 CL E G H23387618162SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE618162OMIM123229165614776
HP:0000964HP:0000964Eczema0SLC30A2 CL E G H7780608118Zinc deficiency, transient neonatal608118C1842486OMIM1191111013609617
HP:0000964HP:0000964Eczema0SMARCA2 CL E G H65953051ORPHA17844511098600014
HP:0000964HP:0000964Eczema0SPINK5 CL E G H11005634Leber congenital amaurosisC0339527ORPHA18938315464605010
HP:0000964HP:0000964Eczema0SRD5A3 CL E G H79644612379Congenital disorder of glycosylation type 1Q612379C3150191OMIM11613925812611715
HP:0000964HP:0000964Eczema0SRP54 CL E G H6729811Balo diseaseORPHA133111301604857
HP:0000964HP:0000964Eczema0STAT1 CL E G H6772391487ORPHA113024911362600555
HP:0000964HP:0000964Eczema0STAT3 CL E G H67742314ORPHA115529111364102582
HP:0000964HP:0000964Eczema0STAT3 CL E G H6774615952Autoimmune disease, multisystem, infantile-onset, 1615952C4014795OMIM115529111364102582
HP:0000964HP:0000964Eczema0SUOX CL E G H6821272300Sulfite oxidase deficiency272300C0268624OMIM12910111460606887
HP:0000964HP:0000964Eczema0TGM5 CL E G H9333263534ORPHA1269711781603805
HP:0000964HP:0000964Eczema0TNFRSF1B CL E G H71332584ORPHA135011917191191
HP:0000964HP:0000964Eczema0TP63 CL E G H8626103285ADULT syndrome103285C1863204OMIM112828215979603273
HP:0000964HP:0000964Eczema0TRPM1 CL E G H4308613216Congenital stationary night blindness, type 1C613216C2750747OMIM1845307146603576
HP:0000964HP:0000964Eczema0WAS CL E G H7454313900Thrombocytopenia, X-linked313900C1839163OMIM144134512731300392
HP:0000964HP:0000964Eczema0WAS CL E G H7454301000Wiskott-Aldrich syndrome301000C0043194OMIM144134512731300392
HP:0000964HP:0000964Eczema1CASP8 CL E G H841607271Caspase-8 deficiency607271C1846545OMIM1121391509601763
HP:0000964HP:0000964Eczema1CD28 CL E G H9402584ORPHA1271653186760
HP:0000964HP:0000964Eczema1CD3G CL E G H917615607Immunodeficiency 17615607C3810107OMIM14851675186740
HP:0000964HP:0000964Eczema1COL1A1 CL E G H1277287ORPHA196711052197120150
HP:0000964HP:0000964Eczema1COL5A1 CL E G H1289287ORPHA115916302209120215
HP:0000964HP:0000964Eczema1COL5A2 CL E G H1290287ORPHA1397932210120190
HP:0000964HP:0000964Eczema1CSTA CL E G H1475263534ORPHA18232481184600
HP:0000964HP:0000964Eczema1CTLA4 CL E G H14932584ORPHA1721142505123890
HP:0000964HP:0000964Eczema1DHCR7 CL E G H1717270400Smith-Lemli-Opitz syndrome270400C0175694OMIM12183762860602858
HP:0000964HP:0000964Eczema1DNAJC21 CL E G H134218811Balo diseaseORPHA1116027030617048
HP:0000964HP:0000964Eczema1DNAJC21 CL E G H134218617052Bone marrow failure syndrome 3617052C4310744OMIM1116027030617048
HP:0000964HP:0000964Eczema1DOCK8 CL E G H81704243700Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive243700C1968689OMIM1169118119191611432
HP:0000964HP:0000964Eczema1EDA CL E G H1896305100Hypohidrotic X-linked ectodermal dysplasia305100C0162359OMIM13303473157300451
HP:0000964HP:0000964Eczema1EFL1 CL E G H79631811Balo diseaseORPHA135725789617538
HP:0000964HP:0000964Eczema1FECH CL E G H2235177000Erythropoietic protoporphyria177000C0162568OMIM11952173647612386
HP:0000964HP:0000964Eczema1FOXP3 CL E G H50943304790Insulin-dependent diabetes mellitus secretory diarrhea syndrome304790C0342288OMIM11082566106300292
HP:0000964HP:0000964Eczema1GINS1 CL E G H9837617827IMMUNODEFICIENCY 55617827CN737162OMIM143728980610608
HP:0000964HP:0000964Eczema1HDAC4 CL E G H97591001Branchial arch defectsORPHA11622314063605314
HP:0000964HP:0000964Eczema1HLA-DQB1 CL E G H3119703ORPHA115124944604305
HP:0000964HP:0000964Eczema1HLA-DRB1 CL E G H3123703ORPHA126194948142857
HP:0000964HP:0000964Eczema1IL2RA CL E G H3559606367Interleukin 2 receptor, alpha, deficiency of606367C1853392OMIM1191766008147730
HP:0000964HP:0000964Eczema1IL7R CL E G H3575608971Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive608971C1837028OMIM1592406024146661
HP:0000964HP:0000964Eczema1KANSL1 CL E G H284058610443Koolen-de Vries syndrome610443C1864871OMIM17284024565612452
HP:0000964HP:0000964Eczema1KRT1 CL E G H38482199ExencephalyORPHA1651336412139350
HP:0000964HP:0000964Eczema1KRT16 CL E G H38682199ExencephalyORPHA131596423148067
HP:0000964HP:0000964Eczema1KRT9 CL E G H38572199ExencephalyORPHA1311096447607606
HP:0000964HP:0000964Eczema1LIG4 CL E G H3981235ORPHA1403176601601837
HP:0000964HP:0000964Eczema1MBTPS2 CL E G H513602273Fara Chlupackova syndromeORPHA12620715455300294
HP:0000964HP:0000964Eczema1MSN CL E G H4478300988Immunodeficiency 50300988C4310812OMIM121347373309845
HP:0000964HP:0000964Eczema1MYSM1 CL E G H114803618116BONE MARROW FAILURE SYNDROME 4618116CN253834OMIM132629401612176
HP:0000964HP:0000964Eczema1NOD2 CL E G H64127186580Blau syndrome186580C1861303OMIM11214425331605956
HP:0000964HP:0000964Eczema1NSMCE3 CL E G H56160617241Lung disease, immunodeficiency, and chromosome breakage syndrome617241C4310653OMIM121377677608243
HP:0000964HP:0000964Eczema1NSUN2 CL E G H54888235ORPHA1726025994610916
HP:0000964HP:0000964Eczema1PAH CL E G H505379254ORPHA19809208582612349
HP:0000964HP:0000964Eczema1PAH CL E G H5053261600Phenylketonuria261600C0031485OMIM19809208582612349
HP:0000964HP:0000964Eczema1PCCA CL E G H5095606054Propionyl-CoA carboxylase deficiency606054C0268579OMIM11493878653232000
HP:0000964HP:0000964Eczema1PCCB CL E G H5096606054Propionyl-CoA carboxylase deficiency606054C0268579OMIM11313018654232050
HP:0000964HP:0000964Eczema1PGM3 CL E G H5238615816Immunodeficiency 23615816C4014371OMIM1161088907172100
HP:0000964HP:0000964Eczema1PTPRC CL E G H5788608971Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive608971C1837028OMIM182259666151460
HP:0000964HP:0000964Eczema1SBDS CL E G H51119811Balo diseaseORPHA1906019440607444
HP:0000964HP:0000964Eczema1SIK3 CL E G H23387618162SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE618162OMIM123229165614776
HP:0000964HP:0000964Eczema1SLC30A2 CL E G H7780608118Zinc deficiency, transient neonatal608118C1842486OMIM1191111013609617
HP:0000964HP:0000964Eczema1SMARCA2 CL E G H65953051ORPHA17844511098600014
HP:0000964HP:0000964Eczema1SPINK5 CL E G H11005634Leber congenital amaurosisC0339527ORPHA18938315464605010
HP:0000964HP:0000964Eczema1SRD5A3 CL E G H79644612379Congenital disorder of glycosylation type 1Q612379C3150191OMIM11613925812611715
HP:0000964HP:0000964Eczema1SRP54 CL E G H6729811Balo diseaseORPHA133111301604857
HP:0000964HP:0000964Eczema1STAT1 CL E G H6772391487ORPHA113024911362600555
HP:0000964HP:0000964Eczema1STAT3 CL E G H67742314ORPHA115529111364102582
HP:0000964HP:0000964Eczema1STAT3 CL E G H6774615952Autoimmune disease, multisystem, infantile-onset, 1615952C4014795OMIM115529111364102582
HP:0000964HP:0000964Eczema1SUOX CL E G H6821272300Sulfite oxidase deficiency272300C0268624OMIM12910111460606887
HP:0000964HP:0000964Eczema1TGM5 CL E G H9333263534ORPHA1269711781603805
HP:0000964HP:0000964Eczema1TNFRSF1B CL E G H71332584ORPHA135011917191191
HP:0000964HP:0000964Eczema1TP63 CL E G H8626103285ADULT syndrome103285C1863204OMIM112828215979603273
HP:0000964HP:0000964Eczema1TRPM1 CL E G H4308613216Congenital stationary night blindness, type 1C613216C2750747OMIM1845307146603576
HP:0000964HP:0000964Eczema1WAS CL E G H7454313900Thrombocytopenia, X-linked313900C1839163OMIM144134512731300392
HP:0000964HP:0000964Eczema1WAS CL E G H7454301000Wiskott-Aldrich syndrome301000C0043194OMIM144134512731300392
HP:0000964HP:0000964Eczema2CASP8 CL E G H841607271Caspase-8 deficiency607271C1846545OMIM1121391509601763
HP:0000964HP:0000964Eczema2CD28 CL E G H9402584ORPHA1271653186760
HP:0000964HP:0000964Eczema2CD3G CL E G H917615607Immunodeficiency 17615607C3810107OMIM14851675186740
HP:0000964HP:0000964Eczema2COL1A1 CL E G H1277287ORPHA196711052197120150
HP:0000964HP:0000964Eczema2COL5A1 CL E G H1289287ORPHA115916302209120215
HP:0000964HP:0000964Eczema2COL5A2 CL E G H1290287ORPHA1397932210120190
HP:0000964HP:0000964Eczema2CSTA CL E G H1475263534ORPHA18232481184600
HP:0000964HP:0000964Eczema2CTLA4 CL E G H14932584ORPHA1721142505123890
HP:0000964HP:0000964Eczema2DHCR7 CL E G H1717270400Smith-Lemli-Opitz syndrome270400C0175694OMIM12183762860602858
HP:0000964HP:0000964Eczema2DNAJC21 CL E G H134218811Balo diseaseORPHA1116027030617048
HP:0000964HP:0000964Eczema2DNAJC21 CL E G H134218617052Bone marrow failure syndrome 3617052C4310744OMIM1116027030617048
HP:0000964HP:0000964Eczema2DOCK8 CL E G H81704243700Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive243700C1968689OMIM1169118119191611432
HP:0000964HP:0000964Eczema2EDA CL E G H1896305100Hypohidrotic X-linked ectodermal dysplasia305100C0162359OMIM13303473157300451
HP:0000964HP:0000964Eczema2EFL1 CL E G H79631811Balo diseaseORPHA135725789617538
HP:0000964HP:0000964Eczema2FECH CL E G H2235177000Erythropoietic protoporphyria177000C0162568OMIM11952173647612386
HP:0000964HP:0000964Eczema2FOXP3 CL E G H50943304790Insulin-dependent diabetes mellitus secretory diarrhea syndrome304790C0342288OMIM11082566106300292
HP:0000964HP:0000964Eczema2GINS1 CL E G H9837617827IMMUNODEFICIENCY 55617827CN737162OMIM143728980610608
HP:0000964HP:0000964Eczema2HDAC4 CL E G H97591001Branchial arch defectsORPHA11622314063605314
HP:0000964HP:0000964Eczema2HLA-DQB1 CL E G H3119703ORPHA115124944604305
HP:0000964HP:0000964Eczema2HLA-DRB1 CL E G H3123703ORPHA126194948142857
HP:0000964HP:0000964Eczema2IL2RA CL E G H3559606367Interleukin 2 receptor, alpha, deficiency of606367C1853392OMIM1191766008147730
HP:0000964HP:0000964Eczema2IL7R CL E G H3575608971Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive608971C1837028OMIM1592406024146661
HP:0000964HP:0000964Eczema2KANSL1 CL E G H284058610443Koolen-de Vries syndrome610443C1864871OMIM17284024565612452
HP:0000964HP:0000964Eczema2KRT1 CL E G H38482199ExencephalyORPHA1651336412139350
HP:0000964HP:0000964Eczema2KRT16 CL E G H38682199ExencephalyORPHA131596423148067
HP:0000964HP:0000964Eczema2KRT9 CL E G H38572199ExencephalyORPHA1311096447607606
HP:0000964HP:0000964Eczema2LIG4 CL E G H3981235ORPHA1403176601601837
HP:0000964HP:0000964Eczema2MBTPS2 CL E G H513602273Fara Chlupackova syndromeORPHA12620715455300294
HP:0000964HP:0000964Eczema2MSN CL E G H4478300988Immunodeficiency 50300988C4310812OMIM121347373309845
HP:0000964HP:0000964Eczema2MYSM1 CL E G H114803618116BONE MARROW FAILURE SYNDROME 4618116CN253834OMIM132629401612176
HP:0000964HP:0000964Eczema2NOD2 CL E G H64127186580Blau syndrome186580C1861303OMIM11214425331605956
HP:0000964HP:0000964Eczema2NSMCE3 CL E G H56160617241Lung disease, immunodeficiency, and chromosome breakage syndrome617241C4310653OMIM121377677608243
HP:0000964HP:0000964Eczema2NSUN2 CL E G H54888235ORPHA1726025994610916
HP:0000964HP:0000964Eczema2PAH CL E G H505379254ORPHA19809208582612349
HP:0000964HP:0000964Eczema2PAH CL E G H5053261600Phenylketonuria261600C0031485OMIM19809208582612349
HP:0000964HP:0000964Eczema2PCCA CL E G H5095606054Propionyl-CoA carboxylase deficiency606054C0268579OMIM11493878653232000
HP:0000964HP:0000964Eczema2PCCB CL E G H5096606054Propionyl-CoA carboxylase deficiency606054C0268579OMIM11313018654232050
HP:0000964HP:0000964Eczema2PGM3 CL E G H5238615816Immunodeficiency 23615816C4014371OMIM1161088907172100
HP:0000964HP:0000964Eczema2PTPRC CL E G H5788608971Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive608971C1837028OMIM182259666151460
HP:0000964HP:0000964Eczema2SBDS CL E G H51119811Balo diseaseORPHA1906019440607444
HP:0000964HP:0000964Eczema2SIK3 CL E G H23387618162SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE618162OMIM123229165614776
HP:0000964HP:0000964Eczema2SLC30A2 CL E G H7780608118Zinc deficiency, transient neonatal608118C1842486OMIM1191111013609617
HP:0000964HP:0000964Eczema2SMARCA2 CL E G H65953051ORPHA17844511098600014
HP:0000964HP:0000964Eczema2SPINK5 CL E G H11005634Leber congenital amaurosisC0339527ORPHA18938315464605010
HP:0000964HP:0000964Eczema2SRD5A3 CL E G H79644612379Congenital disorder of glycosylation type 1Q612379C3150191OMIM11613925812611715
HP:0000964HP:0000964Eczema2SRP54 CL E G H6729811Balo diseaseORPHA133111301604857
HP:0000964HP:0000964Eczema2STAT1 CL E G H6772391487ORPHA113024911362600555
HP:0000964HP:0000964Eczema2STAT3 CL E G H67742314ORPHA115529111364102582
HP:0000964HP:0000964Eczema2STAT3 CL E G H6774615952Autoimmune disease, multisystem, infantile-onset, 1615952C4014795OMIM115529111364102582
HP:0000964HP:0000964Eczema2SUOX CL E G H6821272300Sulfite oxidase deficiency272300C0268624OMIM12910111460606887
HP:0000964HP:0000964Eczema2TGM5 CL E G H9333263534ORPHA1269711781603805
HP:0000964HP:0000964Eczema2TNFRSF1B CL E G H71332584ORPHA135011917191191
HP:0000964HP:0000964Eczema2TP63 CL E G H8626103285ADULT syndrome103285C1863204OMIM112828215979603273
HP:0000964HP:0000964Eczema2TRPM1 CL E G H4308613216Congenital stationary night blindness, type 1C613216C2750747OMIM1845307146603576
HP:0000964HP:0000964Eczema2WAS CL E G H7454313900Thrombocytopenia, X-linked313900C1839163OMIM144134512731300392
HP:0000964HP:0000964Eczema2WAS CL E G H7454301000Wiskott-Aldrich syndrome301000C0043194OMIM144134512731300392
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000964HP:0000964Eczema0CARD14 CL E G H790922897Hypogonadism, isolated, hypogonadotropicORPHA04231816446607211
HP:0000964HP:0000964Eczema0CASR CL E G H846428Autosomal dominant hypocalcemiaCN228164ORPHA04109551514601199
HP:0000964HP:0000964Eczema0CTLA4 CL E G H1493616100Autoimmune lymphoproliferatiVe syndrome, type V616100C4015214OMIM0721142505123890
HP:0000964HP:0000964Eczema0CYBA CL E G H1535379ORPHA0761792577608508
HP:0000964HP:0000964Eczema0CYBB CL E G H1536379ORPHA07823762578300481
HP:0000964HP:0000964Eczema0CYBC1 CL E G H79415379ORPHA0133286720
HP:0000964HP:0000964Eczema0EDAR CL E G H109131810Der Kaloustian Mcintosh Silver syndromeORPHA0622332895604095
HP:0000964HP:0000964Eczema0EDARADD CL E G H1281781810Der Kaloustian Mcintosh Silver syndromeORPHA01015314341606603
HP:0000964HP:0000964Eczema0FECH CL E G H223579278ORPHA01952173647612386
HP:0000964HP:0000964Eczema0FLI1 CL E G H2313617443Bleeding disorder, platelet-type, 21617443C4479515OMIM071253749193067
HP:0000964HP:0000964Eczema0FLI1 CL E G H23132308Fetal minoxidil syndromeORPHA071253749193067
HP:0000964HP:0000964Eczema0GNA11 CL E G H2767428Autosomal dominant hypocalcemiaCN228164ORPHA011624379139313
HP:0000964HP:0000964Eczema0HPGD CL E G H32481525ORPHA0181455154601688
HP:0000964HP:0000964Eczema0KDF1 CL E G H1266951810Der Kaloustian Mcintosh Silver syndromeORPHA021626624616758
HP:0000964HP:0000964Eczema0LBR CL E G H3930169400Pelger-Huët anomaly169400C0030779OMIM0281726518600024
HP:0000964HP:0000964Eczema0NCF1 CL E G H653361379ORPHA048867660608512
HP:0000964HP:0000964Eczema0NCF2 CL E G H4688379ORPHA0791837661608515
HP:0000964HP:0000964Eczema0NCF4 CL E G H4689379ORPHA0131197662601488
HP:0000964HP:0000964Eczema0NSUN2 CL E G H54888611091Mental retardation, autosomal recessive 5611091C1970199OMIM0726025994610916
HP:0000964HP:0000964Eczema0RBCK1 CL E G H10616615895Polyglucosan body myopathy 1 with or without immunodeficiency615895C4014605OMIM01417815864610924
HP:0000964HP:0000964Eczema0RNU4ATAC CL E G H100151683616651Roifman syndrome616651C1846059OMIM0245634016601428
HP:0000964HP:0000964Eczema0SHOC2 CL E G H8036607721Noonan syndrome-like disorder with loose anagen hair 1607721C1843181OMIM0418415454602775
HP:0000964HP:0000964Eczema0SMARCA2 CL E G H6595601358Nicolaides-Baraitser syndrome601358C1303073OMIM07844511098600014
HP:0000964HP:0000964Eczema0STAT1 CL E G H6772614162Immunodeficiency 31C614162C3279990OMIM013024911362600555
HP:0000964HP:0000964Eczema0TAF1 CL E G H6872300966Mental retardation, X-linked, syndromic 33300966C4225418OMIM01724011535313650
HP:0000964HP:0000964Eczema0TRAF6 CL E G H71891810Der Kaloustian Mcintosh Silver syndromeORPHA022312036602355
HP:0000964HP:0000964Eczema0WAS CL E G H7454906ORPHA044134512731300392
HP:0000964HP:0000964Eczema0WIPF1 CL E G H7456906ORPHA0310512736602357
HP:0000964HP:0000964Eczema0WIPF1 CL E G H7456614493Wiskott-Aldrich syndrome 2614493C3281001OMIM0310512736602357
HP:0000964HP:0000964Eczema1CARD14 CL E G H790922897Hypogonadism, isolated, hypogonadotropicORPHA04231816446607211
HP:0000964HP:0000964Eczema1CASR CL E G H846428Autosomal dominant hypocalcemiaCN228164ORPHA04109551514601199
HP:0000964HP:0000964Eczema1CTLA4 CL E G H1493616100Autoimmune lymphoproliferatiVe syndrome, type V616100C4015214OMIM0721142505123890
HP:0000964HP:0000964Eczema1CYBA CL E G H1535379ORPHA0761792577608508
HP:0000964HP:0000964Eczema1CYBB CL E G H1536379ORPHA07823762578300481
HP:0000964HP:0000964Eczema1CYBC1 CL E G H79415379ORPHA0133286720
HP:0000964HP:0000964Eczema1EDAR CL E G H109131810Der Kaloustian Mcintosh Silver syndromeORPHA0622332895604095
HP:0000964HP:0000964Eczema1EDARADD CL E G H1281781810Der Kaloustian Mcintosh Silver syndromeORPHA01015314341606603
HP:0000964HP:0000964Eczema1FECH CL E G H223579278ORPHA01952173647612386
HP:0000964HP:0000964Eczema1FLI1 CL E G H2313617443Bleeding disorder, platelet-type, 21617443C4479515OMIM071253749193067
HP:0000964HP:0000964Eczema1FLI1 CL E G H23132308Fetal minoxidil syndromeORPHA071253749193067
HP:0000964HP:0000964Eczema1GNA11 CL E G H2767428Autosomal dominant hypocalcemiaCN228164ORPHA011624379139313
HP:0000964HP:0000964Eczema1HPGD CL E G H32481525ORPHA0181455154601688
HP:0000964HP:0000964Eczema1KDF1 CL E G H1266951810Der Kaloustian Mcintosh Silver syndromeORPHA021626624616758
HP:0000964HP:0000964Eczema1LBR CL E G H3930169400Pelger-Huët anomaly169400C0030779OMIM0281726518600024
HP:0000964HP:0000964Eczema1NCF1 CL E G H653361379ORPHA048867660608512
HP:0000964HP:0000964Eczema1NCF2 CL E G H4688379ORPHA0791837661608515
HP:0000964HP:0000964Eczema1NCF4 CL E G H4689379ORPHA0131197662601488
HP:0000964HP:0000964Eczema1NSUN2 CL E G H54888611091Mental retardation, autosomal recessive 5611091C1970199OMIM0726025994610916
HP:0000964HP:0000964Eczema1RBCK1 CL E G H10616615895Polyglucosan body myopathy 1 with or without immunodeficiency615895C4014605OMIM01417815864610924
HP:0000964HP:0000964Eczema1RNU4ATAC CL E G H100151683616651Roifman syndrome616651C1846059OMIM0245634016601428
HP:0000964HP:0000964Eczema1SHOC2 CL E G H8036607721Noonan syndrome-like disorder with loose anagen hair 1607721C1843181OMIM0418415454602775
HP:0000964HP:0000964Eczema1SMARCA2 CL E G H6595601358Nicolaides-Baraitser syndrome601358C1303073OMIM07844511098600014
HP:0000964HP:0000964Eczema1STAT1 CL E G H6772614162Immunodeficiency 31C614162C3279990OMIM013024911362600555
HP:0000964HP:0000964Eczema1TAF1 CL E G H6872300966Mental retardation, X-linked, syndromic 33300966C4225418OMIM01724011535313650
HP:0000964HP:0000964Eczema1TRAF6 CL E G H71891810Der Kaloustian Mcintosh Silver syndromeORPHA022312036602355
HP:0000964HP:0000964Eczema1WAS CL E G H7454906ORPHA044134512731300392
HP:0000964HP:0000964Eczema1WIPF1 CL E G H7456906ORPHA0310512736602357
HP:0000964HP:0000964Eczema1WIPF1 CL E G H7456614493Wiskott-Aldrich syndrome 2614493C3281001OMIM0310512736602357
HP:0000964HP:0000964Eczema2CARD14 CL E G H790922897Hypogonadism, isolated, hypogonadotropicORPHA04231816446607211
HP:0000964HP:0000964Eczema2CASR CL E G H846428Autosomal dominant hypocalcemiaCN228164ORPHA04109551514601199
HP:0000964HP:0000964Eczema2CTLA4 CL E G H1493616100Autoimmune lymphoproliferatiVe syndrome, type V616100C4015214OMIM0721142505123890
HP:0000964HP:0000964Eczema2CYBA CL E G H1535379ORPHA0761792577608508
HP:0000964HP:0000964Eczema2CYBB CL E G H1536379ORPHA07823762578300481
HP:0000964HP:0000964Eczema2CYBC1 CL E G H79415379ORPHA0133286720
HP:0000964HP:0000964Eczema2EDAR CL E G H109131810Der Kaloustian Mcintosh Silver syndromeORPHA0622332895604095
HP:0000964HP:0000964Eczema2EDARADD CL E G H1281781810Der Kaloustian Mcintosh Silver syndromeORPHA01015314341606603
HP:0000964HP:0000964Eczema2FECH CL E G H223579278ORPHA01952173647612386
HP:0000964HP:0000964Eczema2FLI1 CL E G H2313617443Bleeding disorder, platelet-type, 21617443C4479515OMIM071253749193067
HP:0000964HP:0000964Eczema2FLI1 CL E G H23132308Fetal minoxidil syndromeORPHA071253749193067
HP:0000964HP:0000964Eczema2GNA11 CL E G H2767428Autosomal dominant hypocalcemiaCN228164ORPHA011624379139313
HP:0000964HP:0000964Eczema2HPGD CL E G H32481525ORPHA0181455154601688
HP:0000964HP:0000964Eczema2KDF1 CL E G H1266951810Der Kaloustian Mcintosh Silver syndromeORPHA021626624616758
HP:0000964HP:0000964Eczema2LBR CL E G H3930169400Pelger-Huët anomaly169400C0030779OMIM0281726518600024
HP:0000964HP:0000964Eczema2NCF1 CL E G H653361379ORPHA048867660608512
HP:0000964HP:0000964Eczema2NCF2 CL E G H4688379ORPHA0791837661608515
HP:0000964HP:0000964Eczema2NCF4 CL E G H4689379ORPHA0131197662601488
HP:0000964HP:0000964Eczema2NSUN2 CL E G H54888611091Mental retardation, autosomal recessive 5611091C1970199OMIM0726025994610916
HP:0000964HP:0000964Eczema2RBCK1 CL E G H10616615895Polyglucosan body myopathy 1 with or without immunodeficiency615895C4014605OMIM01417815864610924
HP:0000964HP:0000964Eczema2RNU4ATAC CL E G H100151683616651Roifman syndrome616651C1846059OMIM0245634016601428
HP:0000964HP:0000964Eczema2SHOC2 CL E G H8036607721Noonan syndrome-like disorder with loose anagen hair 1607721C1843181OMIM0418415454602775
HP:0000964HP:0000964Eczema2SMARCA2 CL E G H6595601358Nicolaides-Baraitser syndrome601358C1303073OMIM07844511098600014
HP:0000964HP:0000964Eczema2STAT1 CL E G H6772614162Immunodeficiency 31C614162C3279990OMIM013024911362600555
HP:0000964HP:0000964Eczema2TAF1 CL E G H6872300966Mental retardation, X-linked, syndromic 33300966C4225418OMIM01724011535313650
HP:0000964HP:0000964Eczema2TRAF6 CL E G H71891810Der Kaloustian Mcintosh Silver syndromeORPHA022312036602355
HP:0000964HP:0000964Eczema2WAS CL E G H7454906ORPHA044134512731300392
HP:0000964HP:0000964Eczema2WIPF1 CL E G H7456906ORPHA0310512736602357
HP:0000964HP:0000964Eczema2WIPF1 CL E G H7456614493Wiskott-Aldrich syndrome 2614493C3281001OMIM0310512736602357


Genes (102) :ARVCF BRAF BTD C5 CARD11 CARD14 CARMIL2 CASP8 CASR CD28 CD3G COL1A1 COL5A1 COL5A2 COMT CSTA CTLA4 CYBA CYBB CYBC1 DHCR7 DNAJC21 DOCK8 EDA EDAR EDARADD EFL1 FECH FLG FLI1 FOXP3 GINS1 GNA11 GP1BB HDAC4 HIRA HLA-DQB1 HLA-DRB1 HLCS HPGD HSPA9 IFIH1 IL2RA IL7R JMJD1C KANSL1 KDF1 KRT1 KRT16 KRT9 LBR LIG4 MBTPS2 MCCC2 MSN MYSM1 NCF1 NCF2 NCF4 NEK9 NOD2 NSMCE3 NSUN2 PAH PCCA PCCB PGM3 PIGA PIK3CA PTPRC RBCK1 RBM8A RNU4ATAC RREB1 SBDS SEC24C SHOC2 SIK3 SLC30A2 SLCO2A1 SMARCA2 SPINK5 SRD5A3 SRP54 STAT1 STAT3 SUOX TAF1 TBX1 TGM5 TMC6 TMC8 TNFRSF1B TP63 TRAF6 TRPM1 UFD1 WAS WIPF1 ZAP70 ZNF341 ZNF750

Diseases (91) :2897 607271 428 2584 615607 287 263534 616100 379 270400 811 617052 243700 305100 1810 79278 177000 617443 2308 304790 617827 1001 703 1525 606367 608971 610443 2199 169400 235 2273 300988 618116 186580 617241 611091 79254 261600 606054 615816 615895 616651 607721 618162 608118 3051 601358 634 612379 391487 614162 2314 615952 272300 300966 103285 613216 906 313900 301000 614493 567 115150 79241 253260 617638 618131 233690 306400 217390 146700 79242 2796 259100 616854 615846 210210 233700 233710 613960 614262 300868 276280 274000 147060 188400 302 269840 618282 610227 609536
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is June 2019 release.